Dr. A.P.J. Abdul Kalam has inaugurated TRICell - Stem Cell Centeron 28th November 2007, Wednesday at 4:00pm
About TRICell - Stem Cell Center
Services presently offered at TRICell-SRU Center
In patient care of hematological malignancies
Bone Marrow Transplantation
Active chemotherapy and supportive care
Management of hematological Disorders that includes work up of anemia patients and bone marrow failure conditions like Aplastic anemia, Fanconi anemia etc.
Management of other allied disorders like Acute and Chronic Leukemia, Lymphoma, Myeloma, Myelodysplastic syndrome etc.
Allogenic and Autologous Bone marrow Transplantaion and Umbilical Cord Blood Stem Cell transplantation.
Day care services for chemotherapy and blood transfusion
Apheresis services like platelet separation, Stem cell separation and Plasma exchange.
To provide consultation services for various hematological problems.
Facilities
TRICell centre has a world class state of art facility with 8 HEPA (High Efficiency Particulate Air filters) classified single rooms which will not allow particles less than 0.3 microns., pretransplantation preparatory room with separate day care ward.
This unit is specially built as infection free zone.
Flooring. This unit is fully coated with Epoxy flooring as they are resistant to fungal &other microbial organisms.
Specialized equipment Blood Irradiator
TRICell is Equipped with Blood irradiator as Irradiation of Blood products is necessary for centers undertaking treatment of cancer patients & bone marrow transplantation patients. However it is notable that this department is amongst the few centers in the country having this facility since only lessthan10 percent of healthcare institutions in India are equipped with blood irradiators for therapy.
Irradiation of blood & blood products by gamma rays is a proven and safe method to inhibit T-Lymphocyte proliferation and eliminate the risk of post transfusion graft-versus-host-disease (T-GVHD). Gamma irradiation of cellular blood components is the best current technology to reduce the risk of T-GVHD to the recipients as confirmed by research.
We have treated numerous Anemia, thalassemia&other hematological disorder patients.
